MRK vs AMGN
By Alex · Tickerpine
Merck & Company, Inc. vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | AMGN |
|---|---|---|
| Price | $132.92 | $416.18 |
| Market cap | $327.94B | $225.15B |
| P/E ratio | 106.3 | 25.7 |
| ROE | 6.96% | 91.47% |
| Profit margin | 4.77% | 22.95% |
| Revenue growth | 5.10% | 9.50% |
| Dividend yield | 2.56% | 2.43% |
| Beta | 0.21 | 0.41 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs AMGN in plain English
- MRK is the bigger company — about 1.5× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 25.7 vs 106.3).
- AMGN earns a higher return on equity (91% vs 7%).
- AMGN is growing revenue faster (10% vs 5%).
- MRK has the higher dividend yield (2.56% vs 2.43%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.